CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax of $2.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2026-06-30 was $2.39M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2025-09-30 was $3.73M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2025-06-30 was -$6.84M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2025-03-31 was -$3.67M, a 182.49% decline year-over-year.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 9 month |
|---|---|---|---|
| 2026-06-30 | $2.39M 10-Q · filed 2026-07-29 | $5.46M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $3.73M 10-Q · filed 2025-11-06 | -$3.11M derived: sum of 2 quarters · filed 2026-07-29 | -$6.78M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$6.84M 10-Q · filed 2026-07-29 | -$10.51M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | -$3.67M 10-Q · filed 2025-05-01 | ||
| 2024-09-30 | -$7.08M 10-Q · filed 2025-11-06 | -$8.95M derived: sum of 2 quarters · filed 2025-11-06 | -$4.50M 10-Q · filed 2025-11-06 |
| 2024-06-30 | -$1.87M 10-Q · filed 2025-07-31 | $2.57M 10-Q · filed 2025-07-31 | |
| 2024-03-31 | $4.45M 10-Q · filed 2025-05-01 | ||
| 2023-09-30 | $2.73M 10-Q · filed 2024-10-31 | $3.23M derived: sum of 2 quarters · filed 2024-10-31 | $4.11M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $503.00K 10-Q · filed 2024-08-01 | $1.38M 10-Q · filed 2024-08-01 | |
| 2023-03-31 | $877.00K 10-Q · filed 2024-04-25 | ||
| 2022-09-30 | $4.83M 10-Q · filed 2023-10-26 | $9.49M derived: sum of 2 quarters · filed 2023-10-26 | $10.58M 10-Q · filed 2023-10-26 |
| 2022-06-30 | $4.66M 10-Q · filed 2023-07-27 | $5.74M 10-Q · filed 2023-07-27 | |
| 2022-03-31 | $1.08M 10-Q · filed 2023-04-27 | ||
| 2021-09-30 | $2.92M 10-Q · filed 2022-10-27 | $4.14M derived: sum of 2 quarters · filed 2022-10-27 | $8.06M 10-Q · filed 2022-10-27 |
| 2021-06-30 | $1.22M 10-Q · filed 2022-07-28 | $5.15M 10-Q · filed 2022-07-28 | |
| 2021-03-31 | $3.93M 10-Q · filed 2022-05-05 | ||
| 2020-09-30 | -$3.03M 10-Q · filed 2021-10-28 | -$5.46M derived: sum of 2 quarters · filed 2021-10-28 | -$3.05M 10-Q · filed 2021-10-28 |
| 2020-06-30 | -$2.43M 10-Q · filed 2021-07-29 | -$24.00K 10-Q · filed 2021-07-29 | |
| 2020-03-31 | $2.40M 10-Q · filed 2021-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |